A simple visual card may boost Patients' grasp of procedure risks
NCT ID NCT07772843
First seen Aug 19, 2026 · Last updated Aug 20, 2026 · Updated 1 time
Summary
This study tests whether giving patients a simplified, illustrated information card before an interventional pain procedure improves their understanding of the consent form. Adults scheduled for such procedures will be randomly assigned to receive either the standard consent process alone or with the extra visual card. After the consent process, their understanding is checked using a teach-back method, where they explain the key points in their own words. The goal is to see if the visual aid makes a meaningful difference in patient comprehension.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- A simplified and visually supported procedure-specific information card
- What this could lead to
- If effective, this simple educational tool could improve how well patients grasp the risks and steps of pain procedures, leading to more informed consent in clinical practice.
- What could go wrong
- The trial is relatively small and measures understanding at one point in time, so results may not apply broadly. The card's benefit may be modest compared to standard consent processes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 360 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 85 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults aged 18 to 85 years. * Patients scheduled to undergo an eligible interventional pain procedure included in the approved study protocol. * Ability to read, understand, and communicate in Turkish. * Ability to understand the study information and provide written informed consent for participation. * Willingness to participate in the study. Exclusion Criteria: * Age below 18 years or above 85 years. * Severe cognitive impairment, mental incapacity, or any condition that prevents reliable understanding of the consent information or completion of the teach-back assessment. * Severe hearing or visual impairment that prevents the participant from receiving or understanding the study information, unless adequately corrected. * Active psychiatric illness or acute psychiatric episode that may affect comprehension, communication, or voluntary consent. * Emergency clinical condition requiring immediate intervention. * Inability or unwillingness to complete the teach-back assessment. * Inability or unwillingness to provide written informed consent for participation.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Patient understanding of informed consent before interventional pain procedures are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
3 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Ankara Bilkent City Hospital
Ankara, Ankara, 06800, Turkey (Türkiye)
-
Sanliurfa Education and Research Hospital
Sanliurfa, Şanlıurfa, 63200, Turkey (Türkiye)
-
Sanliurfa Mehmet Akif Inan Education and Research Hospital
Sanliurfa, Şanlıurfa, 63300, Turkey (Türkiye)